Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) (RFA-CA-27-002)
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed): (RFA-CA-27-002). Its award ceiling of $300,000 is below the median of $1,000,000 (19th percentile). Dated 154 days ago, it serves as a historical benchmark. Score 78/100. As of 2026-11-03, from Grants.gov (U.S. Department of Health and Human Services).
Data as of · Compiled by Zalwin from Grants.gov (U.S. Department of Health and Human Services)
award ceiling: $300,000 · 19th percentile of 142 GrantPulse records · 0.3x the median
Free preview: all 15 published fields of this record are shown below. Locked: 111 related GrantPulse records and the 5-column CSV export.
| Field | Value |
|---|---|
| Opportunity number | RFA-CA-27-002 |
| Title | Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) |
| Agency | National Institutes of Health |
| Status | posted |
| Posted / open date | 2026-06-03 |
| Close date | 2026-11-10 |
| Award ceiling | $300,000 |
| Award floor | n/a |
| Estimated total funding | $5,900,000 |
| Funding category | Health |
| Eligible applicants | Others (see text field entitled "Additional Information on Eligibility" for clarification); Small businesses; Public and State controlled institutions of higher education; Public housing authorities/Indian housing authorities; Private institutions of higher education; State governments; Native American tribal governments (Federally recognized); For profit organizations other than small businesses; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Independent school districts; Special district governments; County governments; City or township governments; Native American tribal organizations (other than Federally recognized tribal governments); Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
| Eligibility notes | Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
| CFDA / Assistance listing | 93.394 |
| Summary | Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites grant applications proposing exploratory research projects focused on further development and technical validation of emerging technologies offering novel capabilities for the molecular or cellular characterization of cancer or for improved handling and quality control of biospecimens used for basic, clinical, or epidemiological cancer research. This NOFO solicits R33 applications where major feasibility gaps for the technology or methodology have been overcome, as demonstrated with supportive preliminary data, but still require further development and rigorous technical validation to encourage ado |
| Agency contact | [email protected] |
| award ceiling percentile | 19th of 142 (median $1,000,000, 0.3x median) |
| Peer records CSV (112 records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Free first: a 10-record sample of records
See the real columns before you buy. One confirmation email, nothing else unless you opt in.
Unlock Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) + all 112 records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Opportunity · Agency · Status · Award ceiling · Closes · official source URL
- Source agency: Grants.gov (U.S. Department of Health and Human Services)
- Record date: 2026-06-03
- Data refreshed: 2026-11-03
- Refunds on request within 14 days
Top GrantPulse records (HHS first): Children’s Hospitals Graduate Medical Education (CHGME · Centers of Excellence in Healthcare Quality and Safety (CDC- · Title X Family Planning Services Grants (PA-FPH-27-001) · Development of Collaborative Research Facilities or Research · Emerging Infections Network - Research for Preventing, Detec · Browse all by state and category →
LIVE PUBLIC DATA Source: Grants.gov (U.S. Department of Health and Human Services) · Last refreshed: Tue, 03 Nov 2026 18:08:06 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) and 112 HHS peers
- HHS GrantPulse records like this one: 112
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)'s award ceiling: 19th percentile of 142 records
- Timing: Low: older than 30 days
- Estimated pipeline if you contact every HHS peer: $22,400 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
78 / 100 Plain-English Eligibility Score
- Small businesses are listed as eligible applicants.
- Nonprofits are listed as eligible applicants.
- Only 6 days until the deadline.
- Award ceiling of $300,000 suits small organizations.
What is the GrantPulse record for Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)?
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) (RFA-CA-27-002) from National Institutes of Health: posted, award ceiling $300,000.
How does Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) compare to other GrantPulse records?
Its award ceiling of $300,000 is below the median (19th percentile); smaller records often move faster and face less competition. It is 154 days old; check the official source for later updates before acting. Its Plain-English Eligibility Score of 78/100 puts it among the stronger signals in this feed.
Get the readiness pack for this opportunity ($4.99)
Eligibility summary, registrations checklist, deadline timeline and a proposal outline, generated from this notice.
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) vs. top 3 peers
| Organization | Location | Combined award ceilings | Percentile | Record date | Compare |
|---|---|---|---|---|---|
| Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) | HHS | $300,000 | 19th | 2026-06-03 | This record |
| Rural Communities Opioid Response Program - Overdose Response | HHS | $300,000 | 19th | 2026-08-21 | Compare Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) vs Rural Communities Opioid Response Program - Overdose Response → |
| Rural Communities Opioid Response Program - Community Systems Development | HHS | $500,000 | 35th | 2026-08-14 | View record → |
| NIOSH Small Research Grant Program (R03) | HHS | $100,000 | 8th | 2026-07-23 | View record → |
Related records
- Rural Communities Opioid Response Program - Overdose Response
- Rural Communities Opioid Response Program - Child and Adolescent Behavioral Health
- Rural Communities Opioid Response Program - Community Systems Development
- Healthy Tomorrows Partnership for Children Program (HTPCP)
- Rural Residency Planning and Development Program
- Rural Health Value Program
- The National Network of STI Prevention Training Centers (NNPTC)
- Comprehensive Suicide Prevention Program for States
- NIOSH Small Research Grant Program (R03)
- NIOSH National Center of Excellence for the Prevention of Childhood Agricultural Injury (U54)
- Research Grants to Rigorously Evaluate Innovative and Promising Approaches to Prevent Firearm-Related Violence and Injuries
- Cooperative Research Agreements Related to the World Trade Center Health Program (U01)
Open and upcoming HHS federal grants Open and upcoming federal grants: Health
How to monitor Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) and peer health records
Get new GrantPulse records like Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get new grants that fit you every week
GrantPulse emails new and forecasted grants matching your organization type and focus areas.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
Data from Grants.gov. Always read the full notice of funding opportunity before applying. Informational only; not legal or grant-writing advice.
Often used together
- FormDPulse
- NsfAwardPulse
- Public Works Prevailing Wage Intent + Environmental Remediation & Tank Retrofit Multi-Signal Trigger
- ContentVelocityRadar
- B2BDomainSignalVerify
- PodcastSponsorRadar
Or get the Advisor Prospecting Bundle for $14.99 one-time: Full CSV unlock of newly funded companies plus a grant readiness pack.